Thomas Craven Baddeley

This inventor holds 19 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignees: Wista Laboratories Ltd., Other. Active years: 2011-2025.

USPTO Granted Patents = 19 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 3

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 7.1

ph-index = 5

Forward Citations = 96(Granted Patents)

Location History:

Aberdeenshire, GB (2013 - 2021)
Old Aberdeen, GB (2011 - 2024)

Company Filing History:

18 out of 59

Wista Laboratories Ltd.

patents

1 out of 834,411

Other

patents

Years Active: 2011-2025

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12324810 - 3, 7-diamino-10H-phenothiazine salts and their use (2025-06-10),

2. 12064439 - Phenothiazine diaminium salts and their use (2024-08-20),

3. 11951110 - 3, 7-diamino-10H-phenothiazine salts and their use (2024-04-09),

4. 11878021 - Methods of synthesis and/or purification of diaminophenothiazinium compounds (2024-01-23),

5. 11344558 - 3, 7-diamino-10H-phenothiazine salts and their use (2022-05-31),

6. 11180464 - Phenothiazine diaminium salts and their use (2021-11-23),

7. 11045477 - Methods of synthesis and/or purification of diaminophenothiazinium compounds (2021-06-29),

8. 10864216 - Phenothiazine diaminium salts and their use (2020-12-15),

9. 10525061 - Methods of synthesis and/or purification of diaminophenothiazinium compounds (2020-01-07),

10. 9980971 - Methods of synthesis and/or purification of diaminophenothiazinium compounds (2018-05-29),

11. 9907804 - Phenothiazine diaminium salts and their use (2018-03-06),

12. 9675621 - Methods of synthesis and/or purification of diaminophenothiazinium compounds (2017-06-13),

13. 9382220 - Methods of synthesis and/or purification of diaminophenothiazinium compounds (2016-07-05),

14. 9283230 - Phenothiazine diaminium salts and their use (2016-03-15),

15. 9174954 - 3,7-diamino-10H-phenothiazine salts and their use (2015-11-03),

Title: Thomas Craven Baddeley: Innovator and Inventor in Pharmaceutical Chemistry

Introduction:

Thomas Craven Baddeley, hailing from Old Aberdeen, GB, is a notable inventor recognized for his contributions to pharmaceutical chemistry. With a remarkable portfolio of 19 patents, he has been instrumental in the development of innovative compounds aimed at treating various diseases, particularly neurodegenerative disorders.

Latest Patents:

Among his recent breakthroughs are the innovative patents concerning the preparation of reduced 3,7-diamino-10H-phenothiazine salts. These patents detail methods for creating high-purity DAPTZ compounds, which are significant in the formulation of stable pharmaceutical compositions. The focus on stability and purity is critical for developing treatments for conditions such as tauopathies, including Alzheimer's disease. Another patent highlights phenothiazine diaminium salts, encompassing formulations and methodologies pertinent to disease treatment.

Career Highlights:

Baddeley has had a prolific career, significantly impacting pharmaceutical science through his inventive works. His expertise in chemical compounds has not only advanced research but also provided new avenues for therapeutic applications. His role at Wista Laboratories Ltd. stands out as a significant phase in his career, where his inventions have gained considerable attention in the industry.

Collaborations:

Throughout his career, Baddeley has collaborated with notable figures such as James Peter Sinclair and Claude Michel Wischik. These partnerships have fostered innovative research and development, enhancing the potential applications of his patented compounds in the realm of medical therapies.

Conclusion:

Thomas Craven Baddeley's contributions to the field of pharmaceutical chemistry are marked by his numerous patents and collaborations. His ongoing work continues to pave the way for advancements in treatments for complex diseases, solidifying his status as a prominent inventor in this vital sector of healthcare.